{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:15:21Z","timestamp":1788304521893,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":82,"publisher":"Springer US","isbn-type":[{"value":"9781071653753","type":"print"},{"value":"9781071653760","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5376-0_30","type":"book-chapter","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:34:35Z","timestamp":1788302075000},"page":"495-507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Use of Microbial Microarrays to Define Antibody Specificity"],"prefix":"10.1007","author":[{"given":"Carter J.","family":"Stowell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin L.","family":"Cepeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William O.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie M.","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Chuen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hau-Ming","family":"Jan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"issue":"7","key":"30_CR1","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1001\/jama.2025.7529","volume":"334","author":"RA Metcalf","year":"2025","unstructured":"Metcalf RA et al (2025) Platelet transfusion: 2025 AABB and ICTMG international clinical practice guidelines. JAMA 334(7):606\u2013617","journal-title":"JAMA"},{"issue":"12","key":"30_CR2","volume":"12","author":"JL Carson","year":"2021","unstructured":"Carson JL et al (2021) Transfusion thresholds for guiding red blood cell transfusion. Cochrane Database Syst Rev 12(12):CD002042","journal-title":"Cochrane Database Syst Rev"},{"key":"30_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.827619","volume":"9","author":"HY Li","year":"2022","unstructured":"Li HY, Guo K (2022) Blood group testing. Front Med (Lausanne) 9:827619","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"30_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.tmrv.2016.05.011","volume":"30","author":"RM Fasano","year":"2016","unstructured":"Fasano RM, Chou ST (2016) Red blood cell antigen genotyping for sickle cell disease, thalassemia, and other transfusion complications. Transfus Med Rev 30(4):197\u2013201","journal-title":"Transfus Med Rev"},{"key":"30_CR5","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1146\/annurev-pathol-042320-110411","volume":"18","author":"CM Arthur","year":"2023","unstructured":"Arthur CM, Stowell SR (2023) The development and consequences of red blood cell Alloimmunization. Annu Rev Pathol 18:537\u2013564","journal-title":"Annu Rev Pathol"},{"key":"30_CR6","volume-title":"The blood group antigen factsbook","author":"ME Reid","year":"2012","unstructured":"Reid ME, Lomas-Francis C, Olsson ML (2012) The blood group antigen factsbook, 3rd edn. Elsevier\/AP, Amsterdam. xii, 745 pages","edition":"3"},{"issue":"2","key":"30_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.21307\/immunohematology-2019-231","volume":"25","author":"JR Storry","year":"2009","unstructured":"Storry JR, Olsson ML (2009) The ABO blood group system revisited: a review and update. Immunohematology 25(2):48\u201359","journal-title":"Immunohematology"},{"issue":"1","key":"30_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105798","volume":"26","author":"RP Jajosky","year":"2023","unstructured":"Jajosky RP et al (2023) ABO blood group antigens and differential glycan expression: perspective on the evolution of common human enzyme deficiencies. iScience 26(1):105798","journal-title":"iScience"},{"key":"30_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1146\/annurev-pathol-012414-040318","volume":"10","author":"JC Zimring","year":"2015","unstructured":"Zimring JC, Spitalnik SL (2015) Pathobiology of transfusion reactions. Annu Rev Pathol 10:83\u2013110","journal-title":"Annu Rev Pathol"},{"key":"30_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/307093","volume":"2012","author":"SR Stowell","year":"2012","unstructured":"Stowell SR et al (2012) Initiation and regulation of complement during hemolytic transfusion reactions. Clin Dev Immunol 2012:307093","journal-title":"Clin Dev Immunol"},{"issue":"2","key":"30_CR11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1056\/NEJMra1802338","volume":"381","author":"SR Panch","year":"2019","unstructured":"Panch SR, Montemayor-Garcia C, Klein HG (2019) Hemolytic transfusion reactions. N Engl J Med 381(2):150\u2013162","journal-title":"N Engl J Med"},{"key":"30_CR12","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.3324\/haematol.2020.262006","volume":"105","author":"S Chonat","year":"2020","unstructured":"Chonat S et al (2020) Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease. Haematologica 105:2887","journal-title":"Haematologica"},{"issue":"807","key":"30_CR13","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adl4922","volume":"17","author":"S Chonat","year":"2025","unstructured":"Chonat S et al (2025) Complement is activated in patients with acute chest syndrome caused by sickle cell disease and represents a therapeutic target. Sci Transl Med 17(807):eadl4922","journal-title":"Sci Transl Med"},{"issue":"23","key":"30_CR14","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1056\/NEJM199006073222301","volume":"322","author":"EP Vichinsky","year":"1990","unstructured":"Vichinsky EP et al (1990) Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 322(23):1617\u20131621","journal-title":"N Engl J Med"},{"issue":"1","key":"30_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1046\/j.1537-2995.2002.00007.x","volume":"42","author":"B Aygun","year":"2002","unstructured":"Aygun B et al (2002) Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 42(1):37\u201343","journal-title":"Transfusion"},{"issue":"3","key":"30_CR16","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/j.1537-2995.2009.02462.x","volume":"50","author":"E Klapper","year":"2010","unstructured":"Klapper E et al (2010) Toward extended phenotype matching: a new operational paradigm for the transfusion service. Transfusion 50(3):536\u2013546","journal-title":"Transfusion"},{"issue":"6","key":"30_CR17","doi-asserted-by":"publisher","first-page":"e468","DOI":"10.1016\/S2352-3026(23)00066-2","volume":"10","author":"F Pirenne","year":"2023","unstructured":"Pirenne F, Floch A, Diop S (2023) Alloimmunisation against red blood cells in sickle cell disease: transfusion challenges in high-income and low-income countries. Lancet Haematol 10(6):e468\u2013e476","journal-title":"Lancet Haematol"},{"issue":"4","key":"30_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2023.104211","volume":"52","author":"DY Chang","year":"2023","unstructured":"Chang DY et al (2023) The ongoing challenge of RBC alloimmunization in the management of patients with sickle cell disease. Presse Med 52(4):104211","journal-title":"Presse Med"},{"issue":"1","key":"30_CR19","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1182\/asheducation-2016.1.452","volume":"2016","author":"JC Zimring","year":"2016","unstructured":"Zimring JC, Hudson KE (2016) Cellular immune responses in red blood cell alloimmunization. Hematology Am Soc Hematol Educ Program 2016(1):452\u2013456","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"30_CR20","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2147\/PHMT.S327032","volume":"12","author":"AK Myle","year":"2021","unstructured":"Myle AK, Al-Khattabi GH (2021) Hemolytic disease of the newborn: a review of current trends and prospects. Pediatr Health Med Ther 12:491\u2013498","journal-title":"Pediatr Health Med Ther"},{"issue":"8","key":"30_CR21","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1182\/blood-2013-03-488874","volume":"122","author":"SR Stowell","year":"2013","unstructured":"Stowell SR et al (2013) Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus\/newborn in a murine model. Blood 122(8):1494\u20131504","journal-title":"Blood"},{"key":"30_CR22","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/s41372-025-02366-2","volume":"45","author":"E Verweij","year":"2025","unstructured":"Verweij E et al (2025) Reporting of management and outcomes in the hemolytic disease of the fetus and newborn: a systematic literature review. J Perinatol 45:1513","journal-title":"J Perinatol"},{"issue":"7","key":"30_CR23","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/vox.70027","volume":"120","author":"MD Kilby","year":"2025","unstructured":"Kilby MD, Bussel JB, Moise KJ Jr (2025) The contemporary management of haemolytic disease of the fetus and newborn. Vox Sang 120(7):644\u2013652","journal-title":"Vox Sang"},{"issue":"16","key":"30_CR24","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1182\/bloodadvances.2023012241","volume":"8","author":"RP Sugrue","year":"2024","unstructured":"Sugrue RP et al (2024) Maternal red blood cell alloimmunization prevalence in the United States. Blood Adv 8(16):4311\u20134319","journal-title":"Blood Adv"},{"issue":"4","key":"30_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.tmrv.2018.07.002","volume":"32","author":"J Webb","year":"2018","unstructured":"Webb J, Delaney M (2018) Red blood cell alloimmunization in the pregnant patient. Transfus Med Rev 32(4):213\u2013219","journal-title":"Transfus Med Rev"},{"issue":"5","key":"30_CR26","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/bjh.15182","volume":"181","author":"MS Karafin","year":"2018","unstructured":"Karafin MS et al (2018) Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database. Br J Haematol 181(5):672\u2013681","journal-title":"Br J Haematol"},{"issue":"1","key":"30_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.tmrv.2018.07.003","volume":"33","author":"RM Fasano","year":"2019","unstructured":"Fasano RM et al (2019) Impact of red blood cell antigen matching on alloimmunization and transfusion complications in patients with sickle cell disease: a systematic review. Transfus Med Rev 33(1):12\u201323","journal-title":"Transfus Med Rev"},{"issue":"3","key":"30_CR28","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1182\/blood-2008-01-132092","volume":"112","author":"EA Hod","year":"2008","unstructured":"Hod EA et al (2008) Cytokine storm in a mouse model of IgG-mediated hemolytic transfusion reactions. Blood 112(3):891\u2013894","journal-title":"Blood"},{"issue":"6","key":"30_CR29","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/j.1537-2995.2012.03910.x","volume":"53","author":"JS Liepkalns","year":"2013","unstructured":"Liepkalns JS et al (2013) Resistance of a subset of red blood cells to clearance by antibodies in a mouse model of incompatible transfusion. Transfusion 53(6):1319\u20131327","journal-title":"Transfusion"},{"issue":"12","key":"30_CR30","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1111\/j.1537-2995.2012.03647.x","volume":"52","author":"JS Liepkalns","year":"2012","unstructured":"Liepkalns JS et al (2012) Biphasic clearance of incompatible red blood cells through a novel mechanism requiring neither complement nor Fcgamma receptors in a murine model. Transfusion 52(12):2631\u20132645","journal-title":"Transfusion"},{"issue":"4","key":"30_CR31","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.tmrv.2019.09.006","volume":"33","author":"CM Arthur","year":"2019","unstructured":"Arthur CM et al (2019) Examining the role of complement in predicting, preventing, and treating hemolytic transfusion reactions. Transfus Med Rev 33(4):217\u2013224","journal-title":"Transfus Med Rev"},{"issue":"2","key":"30_CR32","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1182\/bloodadvances.2020002695","volume":"5","author":"CM Arthur","year":"2021","unstructured":"Arthur CM et al (2021) Antigen density dictates RBC clearance, but not antigen modulation, following incompatible RBC transfusion in mice. Blood Adv 5(2):527\u2013538","journal-title":"Blood Adv"},{"issue":"Suppl 2","key":"30_CR33","first-page":"S74","volume":"55","author":"DR Branch","year":"2015","unstructured":"Branch DR (2015) Anti-A and anti-B: what are they and where do they come from? Transfusion 55(Suppl 2):S74\u2013S79","journal-title":"Transfusion"},{"issue":"1","key":"30_CR34","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1182\/asheducation-2016.1.457","volume":"2016","author":"K Yazdanbakhsh","year":"2016","unstructured":"Yazdanbakhsh K (2016) Immunoregulatory networks in sickle cell alloimmunization. Hematology Am Soc Hematol Educ Program 2016(1):457\u2013461","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"3","key":"30_CR35","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1182\/blood-2011-11-327361","volume":"120","author":"K Yazdanbakhsh","year":"2012","unstructured":"Yazdanbakhsh K, Ware RE, Noizat-Pirenne F (2012) Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood 120(3):528\u2013537","journal-title":"Blood"},{"issue":"22","key":"30_CR36","doi-asserted-by":"publisher","first-page":"5624","DOI":"10.1182\/blood-2008-12-193748","volume":"113","author":"W Bao","year":"2009","unstructured":"Bao W et al (2009) Regulatory T-cell status in red cell alloimmunized responder and nonresponder mice. Blood 113(22):5624\u20135627","journal-title":"Blood"},{"key":"30_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1475470","volume":"15","author":"RP Jajosky","year":"2024","unstructured":"Jajosky RP et al (2024) Dynamics of antibody engagement of red blood cells in vivo and in vitro. Front Immunol 15:1475470","journal-title":"Front Immunol"},{"key":"30_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1548548","volume":"16","author":"RP Jajosky","year":"2025","unstructured":"Jajosky RP et al (2025) CD47 regulates antigen modulation and red blood cell clearance following an incompatible transfusion. Front Immunol 16:1548548","journal-title":"Front Immunol"},{"issue":"1","key":"30_CR39","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/trf.14939","volume":"59","author":"A Mener","year":"2019","unstructured":"Mener A et al (2019) Antibody-mediated immunosuppression can result from RBC antigen loss independent of Fcgamma receptors in mice. Transfusion 59(1):371\u2013384","journal-title":"Transfusion"},{"key":"30_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00676","volume":"9","author":"A Mener","year":"2018","unstructured":"Mener A et al (2018) Complement component 3 negatively regulates antibody response by modulation of red blood cell antigen. Front Immunol 9:676","journal-title":"Front Immunol"},{"issue":"10","key":"30_CR41","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.3324\/haematol.2023.282815","volume":"108","author":"TA Thomas","year":"2023","unstructured":"Thomas TA et al (2023) Reticulocytes in donor blood units enhance red blood cell alloimmunization. Haematologica 108(10):2639\u20132651","journal-title":"Haematologica"},{"issue":"8","key":"30_CR42","doi-asserted-by":"publisher","first-page":"e167665","DOI":"10.1172\/JCI167665","volume":"134","author":"A Jash","year":"2024","unstructured":"Jash A et al (2024) Complement C3 and marginal zone B cells promote IgG-mediated enhancement of RBC alloimmunization in mice. J Clin Invest 134(8):e167665","journal-title":"J Clin Invest"},{"issue":"21","key":"30_CR43","first-page":"2642","volume":"141","author":"R Jajosky","year":"2023","unstructured":"Jajosky R et al (2023) Prior immunization against an intracellular antigen enhances subsequent red blood cell alloimmunization in mice. Blood 141(21):2642\u20132653","journal-title":"Blood"},{"issue":"8","key":"30_CR44","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1182\/blood.2020009376","volume":"138","author":"PE Zerra","year":"2021","unstructured":"Zerra PE et al (2021) Marginal zone B cells mediate a CD4 T-cell-dependent extrafollicular antibody response following RBC transfusion in mice. Blood 138(8):706\u2013721","journal-title":"Blood"},{"issue":"22","key":"30_CR45","doi-asserted-by":"publisher","first-page":"e121631","DOI":"10.1172\/jci.insight.121631","volume":"3","author":"A Mener","year":"2018","unstructured":"Mener A et al (2018) Complement serves as a switch between CD4+ T cell-independent and -dependent RBC antibody responses. JCI Insight 3(22):e121631","journal-title":"JCI Insight"},{"issue":"2","key":"30_CR46","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1182\/bloodadvances.2017010124","volume":"2","author":"SR Patel","year":"2018","unstructured":"Patel SR et al (2018) Recipient priming to one RBC alloantigen directly enhances subsequent alloimmunization in mice. Blood Adv 2(2):105\u2013115","journal-title":"Blood Adv"},{"key":"30_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02516","volume":"9","author":"SR Patel","year":"2018","unstructured":"Patel SR et al (2018) Marginal zone B cells induce alloantibody formation following RBC transfusion. Front Immunol 9:2516","journal-title":"Front Immunol"},{"issue":"3","key":"30_CR48","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.4049\/jimmunol.1700401","volume":"199","author":"DR Gibb","year":"2017","unstructured":"Gibb DR et al (2017) Type I IFN is necessary and sufficient for inflammation-induced red blood cell alloimmunization in mice. J Immunol 199(3):1041\u20131050","journal-title":"J Immunol"},{"issue":"11","key":"30_CR49","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1111\/trf.14288","volume":"57","author":"DR Gibb","year":"2017","unstructured":"Gibb DR et al (2017) B cells require Type 1 interferon to produce alloantibodies to transfused KEL-expressing red blood cells in mice. Transfusion 57(11):2595\u20132608","journal-title":"Transfusion"},{"issue":"7","key":"30_CR50","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.4049\/jimmunol.1601736","volume":"198","author":"CM Arthur","year":"2017","unstructured":"Arthur CM et al (2017) Antigen density dictates immune responsiveness following red blood cell transfusion. J Immunol 198(7):2671\u20132680","journal-title":"J Immunol"},{"issue":"8","key":"30_CR51","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1182\/bloodadvances.2022008411","volume":"7","author":"A Couvidou","year":"2023","unstructured":"Couvidou A et al (2023) Marginal zone B cells are responsible for the production of alloantibodies following platelet transfusion in mice. Blood Adv 7(8):1356\u20131365","journal-title":"Blood Adv"},{"issue":"23","key":"30_CR52","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1182\/blood-2017-05-782912","volume":"130","author":"PE Zerra","year":"2017","unstructured":"Zerra PE et al (2017) Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia a. Blood 130(23):2559\u20132568","journal-title":"Blood"},{"issue":"9","key":"30_CR53","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1182\/blood.2020009210","volume":"139","author":"CM Arthur","year":"2022","unstructured":"Arthur CM et al (2022) Nonhuman glycans can regulate anti-factor VIII antibody formation in mice. Blood 139(9):1312\u20131317","journal-title":"Blood"},{"issue":"14","key":"30_CR54","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1182\/blood-2015-10-673426","volume":"127","author":"CM Arthur","year":"2016","unstructured":"Arthur CM et al (2016) CD8+ T cells mediate antibody-independent platelet clearance in mice. Blood 127(14):1823\u20131827","journal-title":"Blood"},{"issue":"5","key":"30_CR55","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/trf.16872","volume":"62","author":"CM Arthur","year":"2022","unstructured":"Arthur CM et al (2022) Clodronate inhibits alloimmunization against distinct red blood cell alloantigens in mice. Transfusion 62(5):948\u2013953","journal-title":"Transfusion"},{"issue":"3","key":"30_CR56","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1182\/blood-2005-03-1040","volume":"106","author":"JC Zimring","year":"2005","unstructured":"Zimring JC et al (2005) Nonhemolytic antibody-induced loss of erythrocyte surface antigen. Blood 106(3):1105\u20131112","journal-title":"Blood"},{"issue":"22","key":"30_CR57","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1182\/blood-2016-11-749432","volume":"129","author":"HC Sullivan","year":"2017","unstructured":"Sullivan HC et al (2017) Daratumumab (anti-CD38) induces loss of CD38 on red blood cells. Blood 129(22):3033\u20133037","journal-title":"Blood"},{"issue":"10","key":"30_CR58","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1182\/blood-2013-06-508952","volume":"122","author":"KR Girard-Pierce","year":"2013","unstructured":"Girard-Pierce KR et al (2013) A novel role for C3 in antibody-induced red blood cell clearance and antigen modulation. Blood 122(10):1793\u20131801","journal-title":"Blood"},{"issue":"12","key":"30_CR59","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1182\/blood.2022018591","volume":"142","author":"RP Jajosky","year":"2023","unstructured":"Jajosky RP et al (2023) Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression. Blood 142(12):1082\u20131098","journal-title":"Blood"},{"issue":"6","key":"30_CR60","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.ajt.2025.03.001","volume":"25","author":"I Adam","year":"2025","unstructured":"Adam I et al (2025) ABO-A antibody induction in mice is T cell-dependent, estrogen-independent, and modulated by CD22. Am J Transplant 25(6):1180\u20131192","journal-title":"Am J Transplant"},{"issue":"11","key":"30_CR61","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1097\/TP.0000000000004658","volume":"107","author":"I Adam","year":"2023","unstructured":"Adam I et al (2023) Sex, T cells, and the microbiome in natural ABO antibody production in mice. Transplantation 107(11):2353\u20132363","journal-title":"Transplantation"},{"issue":"5","key":"30_CR62","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/vox.12787","volume":"114","author":"CP Stowell","year":"2019","unstructured":"Stowell CP, Stowell SR (2019) Biologic roles of the ABH and Lewis histo-blood group antigens part I: infection and immunity. Vox Sang 114(5):426\u2013442","journal-title":"Vox Sang"},{"issue":"1","key":"30_CR63","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jaci.2023.09.003","volume":"153","author":"RC Hale","year":"2024","unstructured":"Hale RC et al (2024) The role of glycosylation in clinical allergy and immunology. J Allergy Clin Immunol 153(1):55\u201366","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"30_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2024.100747","volume":"23","author":"HM Jan","year":"2024","unstructured":"Jan HM et al (2024) Galectin-4 antimicrobial activity primarily occurs through its C-terminal domain. Mol Cell Proteomics 23(5):100747","journal-title":"Mol Cell Proteomics"},{"key":"30_CR65","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cbpa.2013.12.017","volume":"18","author":"CM Arthur","year":"2014","unstructured":"Arthur CM, Cummings RD, Stowell SR (2014) Using glycan microarrays to understand immunity. Curr Opin Chem Biol 18:55\u201361","journal-title":"Curr Opin Chem Biol"},{"issue":"4","key":"30_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101704","volume":"298","author":"AV Blenda","year":"2022","unstructured":"Blenda AV et al (2022) Galectin-9 recognizes and exhibits antimicrobial activity toward microbes expressing blood group-like antigens. J Biol Chem 298(4):101704","journal-title":"J Biol Chem"},{"issue":"7","key":"30_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104482","volume":"25","author":"SC Wu","year":"2022","unstructured":"Wu SC et al (2022) Innate immune Galectin-7 specifically targets microbes that decorate themselves in blood group-like antigens. iScience 25(7):104482","journal-title":"iScience"},{"issue":"5","key":"30_CR68","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1182\/bloodadvances.2020003259","volume":"5","author":"SC Wu","year":"2021","unstructured":"Wu SC et al (2021) The SARS-CoV-2 receptor-binding domain preferentially recognizes blood group a. Blood Adv 5(5):1305\u20131309","journal-title":"Blood Adv"},{"key":"30_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.731026","volume":"12","author":"SC Wu","year":"2021","unstructured":"Wu SC et al (2021) Full-length Galectin-3 is required for high affinity microbial interactions and antimicrobial activity. Front Microbiol 12:731026","journal-title":"Front Microbiol"},{"issue":"6","key":"30_CR70","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nchembio.1525","volume":"10","author":"SR Stowell","year":"2014","unstructured":"Stowell SR et al (2014) Microbial glycan microarrays define key features of host-microbial interactions. Nat Chem Biol 10(6):470\u2013476","journal-title":"Nat Chem Biol"},{"issue":"8","key":"30_CR71","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1182\/blood.2022018903","volume":"142","author":"SC Wu","year":"2023","unstructured":"Wu SC et al (2023) Blood group A enhances SARS-CoV-2 infection. Blood 142(8):742\u2013747","journal-title":"Blood"},{"issue":"8","key":"30_CR72","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41577-022-00829-7","volume":"23","author":"FT Liu","year":"2023","unstructured":"Liu FT, Stowell SR (2023) The role of galectins in immunity and infection. Nat Rev Immunol 23(8):479\u2013494","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"30_CR73","doi-asserted-by":"publisher","first-page":"15436","DOI":"10.1038\/s41598-020-71967-y","volume":"10","author":"RND Luetscher","year":"2020","unstructured":"Luetscher RND et al (2020) Unique repertoire of anti-carbohydrate antibodies in individual human serum. Sci Rep 10(1):15436","journal-title":"Sci Rep"},{"key":"30_CR74","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1146\/annurev-biochem-061809-152236","volume":"80","author":"CD Rillahan","year":"2011","unstructured":"Rillahan CD, Paulson JC (2011) Glycan microarrays for decoding the glycome. Annu Rev Biochem 80:797\u2013823","journal-title":"Annu Rev Biochem"},{"issue":"15","key":"30_CR75","doi-asserted-by":"publisher","first-page":"10109","DOI":"10.1074\/jbc.M709545200","volume":"283","author":"SR Stowell","year":"2008","unstructured":"Stowell SR et al (2008) Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens. J Biol Chem 283(15):10109\u201310123","journal-title":"J Biol Chem"},{"issue":"29","key":"30_CR76","doi-asserted-by":"publisher","first-page":"20547","DOI":"10.1074\/jbc.M802495200","volume":"283","author":"SR Stowell","year":"2008","unstructured":"Stowell SR et al (2008) Dimeric Galectin-8 induces phosphatidylserine exposure in leukocytes through polylactosamine recognition by the C-terminal domain. J Biol Chem 283(29):20547\u201320559","journal-title":"J Biol Chem"},{"key":"30_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.893185","volume":"9","author":"AD Ho","year":"2022","unstructured":"Ho AD et al (2022) An automated approach to assess relative galectin-glycan affinity following glycan microarray analysis. Front Mol Biosci 9:893185","journal-title":"Front Mol Biosci"},{"issue":"8","key":"30_CR78","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.1074\/jbc.M808925200","volume":"284","author":"SR Stowell","year":"2009","unstructured":"Stowell SR et al (2009) Ligand reduces galectin-1 sensitivity to oxidative inactivation by enhancing dimer formation. J Biol Chem 284(8):4989\u20134999","journal-title":"J Biol Chem"},{"key":"30_CR79","doi-asserted-by":"publisher","first-page":"5697","DOI":"10.1111\/febs.70172","volume":"292","author":"EKC Tulin","year":"2025","unstructured":"Tulin EKC et al (2025) Blood group O expression in normal tissues and tumors. FEBS J 292:5697","journal-title":"FEBS J"},{"issue":"5","key":"30_CR80","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1021\/acscentsci.4c02124","volume":"11","author":"T Jia","year":"2025","unstructured":"Jia T et al (2025) Novel click coupling chemistry to explore glycan recognition. ACS Cent Sci 11(5):753\u2013769","journal-title":"ACS Cent Sci"},{"issue":"5","key":"30_CR81","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.4049\/jimmunol.180.5.3091","volume":"180","author":"SR Stowell","year":"2008","unstructured":"Stowell SR et al (2008) Differential roles of galectin-1 and galectin-3 in regulating leukocyte viability and cytokine secretion. J Immunol 180(5):3091\u20133102","journal-title":"J Immunol"},{"issue":"3","key":"30_CR82","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nm.2103","volume":"16","author":"SR Stowell","year":"2010","unstructured":"Stowell SR et al (2010) Innate immune lectins kill bacteria expressing blood group antigen. Nat Med 16(3):295\u2013301","journal-title":"Nat Med"}],"container-title":["Methods in Molecular Biology","Methods in Transfusion Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5376-0_30","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:34:36Z","timestamp":1788302076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5376-0_30"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071653753","9781071653760"],"references-count":82,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5376-0_30","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}